One of the highlight exhibits at the 2019 NACFC in Nashville was the Innovation Lab, an interactive science fair showcasing how technology is being harnessed to improve cystic fibrosis (CF) treatment. This year the focus was on improving adherence.
The need for people with CF to self-administer a large number of medical interventions (taking medications, using devices, etc) every day creates a treatment burden that adversely affects adherence. Clinicians who stopped by the Innovation Lab received first-hand experience with the breakthrough technologies currently available to help patients overcome adherence challenges.
More than 800 clinicians caring for patients with CF passed through the Innovation Lab during NACFC 2019. Follow-up polling revealed:
Our guest author for this eCysticFibrosis Review Special Edition is Dr. Gabriela Oates, PhD, Assistant Professor at the University of Alabama at Birmingham (UAB) Department of Pediatrics, Division of Pulmonary and Sleep Medicine, and Associate Scientist at the UAB Cystic Fibrosis Research Center. She was also a visitor to the 2019 NACFC Innovation Lab. In this Special Edition issue, Dr. Oates:
Pediatric Pulmonary and Sleep Medicine, The University of Alabama at Birmingham
Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Senior Clinical Nurse
The Johns Hopkins University
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: March 17, 2020
Expiration date: March 16, 2022